Changchun Genescience Pharmaceutical Co., Ltd.

This study tested a new drug called gentuximab combined with the chemotherapy paclitaxel in 76 people with advanced stomach or gastroesophageal junction cancer that had worsened after initial treatment. The goal was to find safe doses and see if the combination could shrink tumor…

This study tested a new tablet, GS1-144, to see if it can reduce moderate to severe hot flashes in postmenopausal women. 129 women took either the drug or a placebo for 12 weeks. The goal was to measure changes in hot flash frequency and severity, as well as quality of life.

This early-stage study tested a single injection of a new drug called GenSci120 in 58 healthy adults in China. The main goal was to check if the drug is safe and how the body processes it. This is a first step before testing the drug in people with autoimmune diseases.